Carbon-dot-mediated co-administration of chemotherapeutic agents for reversing cisplatin resistance in cancer therapy
Chemotherapeutic DNA-modifying cisplatin and topoisomerase II (TOP2)-inhibiting doxorubicin (DOX) were co-administrated by full-color emissive carbon dots (CDs−Pt(IV)−DOX) through tumor intracellular environment responsive covalent bonds to successfully reverse the resistance of cisplatin in cancer...
Saved in:
| Main Authors: | , , |
|---|---|
| 其他作者: | |
| 格式: | Article |
| 語言: | English |
| 出版: |
2020
|
| 主題: | |
| 在線閱讀: | https://hdl.handle.net/10356/140629 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|